A Case of Ulcerative Colitis Relapse Characterized by Systemic Type I Interferon Responses after COVID-19 Vaccination

Yasuhiro Masuta; Tomohiro Watanabe; Kosuke Minaga; Masatoshi Kudo

doi:10.1093/ibd/izac031

Related publications

Letter2022

Reply to Response to “‘A Case of Ulcerative Colitis Relapse Characterized by Systemic Type I Interferon Responses After COVID-19 Vaccination’” by Mungmunpuntipantip and Wiwanitkiton

Yasuhiro Masuta, Tomohiro Watanabe, Kosuke Minaga, Masatoshi Kudo

Article2023

Cytokine and chemokine profiles in ulcerative colitis relapse after coronavirus disease 2019 vaccination

Yasuhiro Masuta, Kosuke Minaga, Yasuo Otsuka, Natsuki Okai, Akane Hara, Sho Masaki, Tomoyuki Nagai, Hajime Honjo, Masatoshi Kudo, Tomohiro Watanabe

Article2021

Hepatitis C Virus Reactivation Following COVID-19 Vaccination – A Case Report

Ruud Lensen, Mihai G. Netea, Frits R. Rosendaal

International Medical Case Reports Journal

Article2017

A Case of Type II Enteropathy-Associated T-Cell Lymphoma in a Patient With Ulcerative Colitis

Yoriaki Komeda, Hiroshi Kashida, Toshiharu Sakurai, Masashi Kono, Tomoyuki Nagai, Yutaka Asakuma, Satoru Hagiwara, Shigenaga Matsui, Tomohiro Watanabe, Takaaki Chikugo, Masatoshi Kudo

Article2022

Distinct type I interferon responses between younger women and older men contribute to the variability of COVID-19 outcomes: Hypothesis generating insights from COVID-19 convalescent individuals

Clio P. Mavragani, Charalampos Skarlis, Ioannis V. Kostopoulos, Eirini Maratou, Paraskevi Moutsatsou, Evangelos Terpos, Ourania Tsitsilonis, Meletios A Dimopoulos, Petros P. Sfikakis